Summary

The global surgical sponges market is valued at an estimated 0.81 billion in 2024 and is projected to reach USD 1.19 billion by 2029, at a CAGR of 7.9% during the forecast period. The rise in trauma cases and accidents, as well as the development of the healthcare infrastructure, are the primary drivers of the surgical sponges market's growth. Sterile surgical sponges and other useful surgical supplies are becoming more and more necessary as the frequency of procedures linked to trauma and accidents rises. Therefore, if trauma and accidents become more widespread, there will likely be a greater need for surgical sponges.
“The x-ray detectable sponges segment is projected to witness highest growth rate in the surgical sponges market, by type, during the forecast period”
Based on type, the surgical sponges market is segmented into x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges. The ability of x-ray detectable sponges to significantly enhance patient safety by reducing the risk of retained surgical items by identifying leftover surgical items such as surgical sponges during surgical procedures, contributes to their extensive usage and market demand during the forecast period.
“The cotton segment is projected to witness the highest growth rate in the surgical sponges market, by material, during the forecast period.”
Based on material, the surgical sponges market is segmented into cotton, rayon, PVA, and other materials. Cotton is cost-effective, it also have high absorbency, and it is easily available material in most of the regions. Which is making cotton a best choice for hospitals and ambulatory surgical centers, especially in high-volume settings. These factors are contributing to growth of this segment.

“The square & rectangle segment is projected to witness the highest growth rate in the surgical sponges market, in 2023, by shape”
Based on shape, the surgical sponges market is segmented into round & cylindrical, square & rectangle, and other shapes. The square and rectangular shapes make surgical sponges suitable for a range of surgical applications where effective blood and other fluid absorption and coverage are required. Which is contributing to their extensive adoption and market demand during the forecast period.
“The hospitals & ambulatory surgery centers segment is projected to witness the highest growth rate in the surgical sponges market in 2023, by end user”.
Based on end users, the surgical sponges market is segmented hospitals & ambulatory surgery centers, and specialty clinics. The expansion of healthcare infrastructure, particularly in emerging markets, has led to an increase in number of hospitals and ASCs, driving demand for surgical sponges among these end users during the forecasted period.
“The Asia Pacific region is projected to witness highest growth rate in the surgical sponges market during the forecast period”
The global surgical sponges market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the surgical sponges market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about illness management and the growing number of hospitals and clinics in China and India.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America – 35%, Europe – 24%, Asia Pacific – 26%, Latin America – 12%, Middle East & Africa – 2%, and the GCC Countries – 1%
Lists of Companies Profiled in the Report:
Johnson & Johnson Services, Inc. (US), Medline Industries, LP (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Dynarex corporation (US), 3M (US), Medicom (Canada), McKesson Corporation (US), Dukal, LLC (US), DeRoyal Industries, Inc. (US), Owens & Minor Inc. (US), AdvaCare Pharma (US), First aid bandage company (US), AllCare (US), Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Aegis Lifesciences (India), SUNDARAM SURGICAL (India), Omni International Corp (US), and Aspen Surgical Products, Inc.(US).
Research Coverage:
In this report, the surgical sponges market has been categorized based on material (cotton, rayon, PVA, and other materials), end user (hospitals & ambulatory surgery centers, and specialty clinics), sterility (sterile surgical sponge, and non-sterile surgical sponge), type (x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges), application (general surgery, neurosurgery, laparotomy, dental surgery, ENT surgery, and other applications), shape (round & cylindrical, square & rectangle, and other shapes), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).
Comprehensive information regarding the main drivers, barriers, opportunities, and trends influencing the surgical sponges market's expansion is included in detail in this study. An exhaustive study of the key players in the surgical sponges market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging surgical sponge startups.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical sponges market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, trends, opportunities, and restaints.
The report provides insights on the following pointers:
• Analysis of key drivers: (Rising number of surgical procedures performed, increasing cases of trauma and accidents, growing gearitric population and increasing prevalence of chronic diseases, and growing healthcare infrastructure), restraints (Risk of retained surgical items (RSIs)), opportunities (Increased adoption of outpatient surgeries, and growth opportunities in emerging economies), and trends (Technological advancements in surgical sponges, and developmentand adoption of biodegradable surgical sponges) influencing the growth of the in surgical sponges market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the surgical sponges market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surgical sponges market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Johnson & Johnson Services, Inc. (US), Cardinal Health (US), and McKesson Corporation (US) are among others, in the surgical sponges market strategies.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Key data from primary sources 33
2.1.2.3 Key industry insights 34
2.1.2.4 Breakdown of primary interviews 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
2.2.2 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
2.4 MARKET SHARE ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.5.1 GROWTH RATE ASSUMPTIONS 41
2.6 RESEARCH LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 42
2.6.2 SCOPE-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 48
4.1 SURGICAL SPONGES MARKET OVERVIEW 48
4.2 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE AND COUNTRY (2023) 49
4.3 SURGICAL SPONGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
4.4 SURGICAL SPONGES MARKET: REGIONAL MIX (2024–2029) 51
4.5 SURGICAL SPONGES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Rising number of surgical procedures performed 53
5.2.1.2 Increasing trauma and accident cases 54
5.2.1.3 Growing geriatric population and increasing prevalence of chronic diseases 54
5.2.1.4 Healthcare infrastructural development and expansion 55
5.2.2 RESTRAINTS 56
5.2.2.1 Risk of retained surgical items 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growth opportunities in emerging economies 57
5.2.3.2 Increased adoption of outpatient surgeries 58
5.2.4 TRENDS 58
5.2.4.1 Development and adoption of biodegradable surgical sponges 58
5.2.4.2 Technological advancements in surgical sponges 58
5.3 PRICING ANALYSIS 59
5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 59
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 60
5.4 VALUE CHAIN ANALYSIS 60
5.5 SUPPLY CHAIN ANALYSIS 61
5.6 ECOSYSTEM ANALYSIS 62
5.6.1 SURGICAL SPONGES MARKET: ROLE IN ECOSYSTEM 63
5.7 PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 THREAT OF NEW ENTRANTS 65
5.7.2 THREAT OF SUBSTITUTES 65
5.7.3 BARGAINING POWER OF SUPPLIERS 66
5.7.4 BARGAINING POWER OF BUYERS 66
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 67
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
5.8.2 BUYING CRITERIA 67
5.9 REGULATORY LANDSCAPE 68
5.9.1 NORTH AMERICA 68
5.9.1.1 US 68
5.9.1.2 Canada 69
5.9.2 EUROPE 69
5.9.3 ASIA PACIFIC 69
5.9.3.1 Japan 69
5.9.3.2 China 70
5.9.3.3 India 71
5.9.4 LATIN AMERICA 71
5.9.4.1 Brazil 71
5.9.4.2 Mexico 71
5.9.5 MIDDLE EAST 72
5.9.6 AFRICA 72
5.9.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
5.10 TRADE ANALYSIS 74
5.10.1 IMPORT DATA FOR SURGICAL SPONGES 74
5.10.2 EXPORT DATA FOR SURGICAL SPONGES 74
5.11 PATENT ANALYSIS 75
5.11.1 LIST OF MAJOR PATENTS 76
5.12 KEY CONFERENCES AND EVENTS, 2024–2025 76
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.14 INVESTMENT & FUNDING SCENARIO 78
5.15 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON SURGICAL SPONGES MARKET 78
6 SURGICAL SPONGES MARKET, BY TYPE 79
6.1 INTRODUCTION 80
6.2 COTTON GAUZE SPONGES 80
6.2.1 SUPERIOR PROPERTIES OF COTTON GAUZE TO PROPEL GROWTH 80
6.3 X-RAY-DETECTABLE SPONGES 83
6.3.1 ENHANCED PATIENT SAFETY TO BOOST DEMAND 83
6.4 NONWOVEN SPONGES 86
6.4.1 LINT-FREE NATURE OF NONWOVEN SPONGES TO DRIVE GROWTH 86
6.5 LAPAROTOMY SPONGES 89
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 89
6.6 OTHER SURGICAL SPONGES 92
7 SURGICAL SPONGES MARKET, BY MATERIAL 95
7.1 INTRODUCTION 96
7.2 COTTON 96
7.2.1 HIGH ABSORBENCY AND WIDE AVAILABILITY TO BOOST MARKET 96
7.3 RAYON 99
7.3.1 EXCEPTIONAL ABSORBENCY AND SOFTNESS TO PROPEL GROWTH 99
7.4 PVA 101
7.4.1 BIOCOMPATIBILITY OF PVA SPONGES TO DRIVE ADOPTION 101
7.5 OTHER MATERIALS 104
 
8 SURGICAL SPONGES MARKET, BY SHAPE 107
8.1 INTRODUCTION 108
8.2 SQUARE & RECTANGLE 108
8.2.1 ADAPTABILITY AND WIDE USE TO BOOST MARKET GROWTH 108
8.3 ROUND & CYLINDRICAL 111
8.3.1 PRECISION AND EASE OF MAINTAINING PATIENT SAFETY TO DRIVE MARKET 111
8.4 OTHER SHAPES 114
9 SURGICAL SPONGES MARKET, BY STERILITY 118
9.1 INTRODUCTION 119
9.2 STERILE SURGICAL SPONGES 119
9.2.1 EMPHASIS ON INFECTION CONTROL AND PREVENTION IN HEALTHCARE SETTINGS TO PROMOTE MARKET GROWTH 119
9.3 NON-STERILE SURGICAL SPONGES 122
9.3.1 WIDE USE IN CLEANING WOUNDS AND DRESSING MINOR INJURIES TO PROPEL GROWTH 122
10 SURGICAL SPONGES MARKET, BY APPLICATION 126
10.1 INTRODUCTION 127
10.2 GENERAL SURGERY 127
10.2.1 RISING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE MARKET 127
10.3 NEUROSURGERY 130
10.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 130
10.4 LAPAROTOMY 133
10.4.1 RISING NUMBER OF LAPAROTOMY PROCEDURES WORLDWIDE TO DRIVE MARKET 133
10.5 DENTAL SURGERY 136
10.5.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH 136
10.6 ENT SURGERY 139
10.6.1 INCREASING DISPOSABLE INCOME AND AFFORDABILITY TO BOOST GROWTH 139
10.7 OTHER APPLICATIONS 142
11 SURGICAL SPONGES MARKET, BY END USER 146
11.1 INTRODUCTION 147
11.2 HOSPITALS & AMBULATORY SURGERY CENTERS 147
11.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS IN HEALTHCARE TO PROMOTE MARKET GROWTH 147
11.3 SPECIALTY CLINICS 150
11.3.1 GROWING NUMBER OF SURGERIES TO DRIVE MARKET 150
 
12 SURGICAL SPONGES MARKET, BY REGION 154
12.1 INTRODUCTION 155
12.2 NORTH AMERICA 155
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156
12.2.2 US 160
12.2.2.1 Strong healthcare infrastructure to support market growth 160
12.2.3 CANADA 163
12.2.3.1 Growing geriatric population and increasing volume of surgeries to drive demand 163
12.3 EUROPE 166
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPEAN UNION 167
12.3.2 GERMANY 170
12.3.2.1 Increasing healthcare expenditure and rising per capita disposable income to propel market 170
12.3.3 UK 173
12.3.3.1 Growing volume of cardiovascular surgeries to drive market 173
12.3.4 FRANCE 176
12.3.4.1 Presence of robust healthcare systems to augment market 176
12.3.5 ITALY 179
12.3.5.1 Rising geriatric population and increasing number of chronic diseases to support market 179
12.3.6 SPAIN 182
12.3.6.1 Growing demand for effective surgical outcomes to create major growth opportunities 182
12.3.7 REST OF EUROPE 185
12.4 ASIA PACIFIC 189
12.4.1 MACROECONOMIC OUTLOOK FOR EAST ASIA & PACIFIC 189
12.4.2 CHINA 193
12.4.2.1 Rising number of hospitals and greater public access to modern healthcare to drive market 193
12.4.3 JAPAN 197
12.4.3.1 Rising prevalence of chronic diseases and robust healthcare system to support market 197
12.4.4 INDIA 200
12.4.4.1 Large patient population and developing healthcare sector to drive market 200
12.4.5 REST OF ASIA PACIFIC 203
12.5 LATIN AMERICA 205
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA & CARIBBEAN 206
12.5.2 BRAZIL 209
12.5.2.1 Increasing cases of accidents and traumas to fuel market 209
12.5.3 MEXICO 212
12.5.3.1 Low-cost surgeries and enhanced healthcare infrastructure to aid market 212
12.5.4 REST OF LATIN AMERICA 215
12.6 MIDDLE EAST & AFRICA 218
12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET 218
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & NORTH AFRICA 219
12.7 GCC COUNTRIES 222
12.7.1 ADVANCEMENTS AND INCREASED GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET 222
12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 223
13 COMPETITIVE LANDSCAPE 227
13.1 OVERVIEW 227
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 227
13.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN SURGICAL SPONGES MARKET 227
13.3 REVENUE ANALYSIS 228
13.4 MARKET SHARE ANALYSIS 229
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 231
13.5.1 STARS 231
13.5.2 EMERGING LEADERS 231
13.5.3 PERVASIVE PLAYERS 231
13.5.4 PARTICIPANTS 231
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 233
13.5.5.1 Company footprint 233
13.5.5.2 Type footprint 234
13.5.5.3 Material footprint 234
13.5.5.4 Shape footprint 235
13.5.5.5 Sterility footprint 235
13.5.5.6 Application footprint 236
13.5.5.7 End-user footprint 236
13.5.5.8 Region footprint 237
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 237
13.6.1 PROGRESSIVE COMPANIES 237
13.6.2 STARTING BLOCKS 237
13.6.3 RESPONSIVE COMPANIES 238
13.6.4 DYNAMIC COMPANIES 238
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 239
13.7 VALUATION & FINANCIAL METRICS 240
13.8 BRAND/PRODUCT COMPARISON 241
13.9 COMPETITIVE SCENARIO 242
13.9.1 DEALS 242
13.9.2 EXPANSIONS 242
13.9.3 OTHER DEVELOPMENTS 242
14 COMPANY PROFILES 243
14.1 KEY PLAYERS 243
14.1.1 JOHNSON & JOHNSON SERVICES, INC. 243
14.1.1.1 Business overview 243
14.1.1.2 Products offered 244
14.1.1.3 MnM view 245
14.1.1.3.1 Right to win 245
14.1.1.3.2 Strategic choices 245
14.1.1.3.3 Weaknesses & competitive threats 245
14.1.2 MCKESSON CORPORATION 246
14.1.2.1 Business overview 246
14.1.2.2 Products offered 247
14.1.2.3 MnM view 247
14.1.2.3.1 Key strengths 247
14.1.2.3.2 Strategic choices 248
14.1.2.3.3 Weaknesses and competitive threats 248
14.1.3 CARDINAL HEALTH 249
14.1.3.1 Business overview 249
14.1.3.2 Products offered 250
14.1.3.3 MnM view 251
14.1.3.3.1 Key strengths 251
14.1.3.3.2 Strategic choices 251
14.1.3.3.3 Weaknesses and competitive threats 251
14.1.4 3M 252
14.1.4.1 Business overview 252
14.1.4.2 Products offered 253
14.1.4.3 Recent developments 254
14.1.4.3.1 Other developments 254
14.1.4.4 MnM view 254
14.1.4.4.1 Key strengths 254
14.1.4.4.2 Strategic choices 254
14.1.4.4.3 Weaknesses and competitive threats 254
14.1.5 INTEGRA LIFESCIENCES CORPORATION 255
14.1.5.1 Business overview 255
14.1.5.2 Products offered 256
14.1.5.3 Recent developments 257
14.1.5.3.1 Deals 257
14.1.6 MEDICOM 258
14.1.6.1 Business overview 258
14.1.6.2 Products offered 258
 
14.1.7 MEDLINE INDUSTRIES, LP. 260
14.1.7.1 Business overview 260
14.1.7.2 Product offered 260
14.1.7.3 Recent developments 261
14.1.7.3.1 Expansions 261
14.1.8 DEROYAL INDUSTRIES, INC. 262
14.1.8.1 Business overview 262
14.1.8.2 Product offered 262
14.1.9 DUKAL LLC 263
14.1.9.1 Business overview 263
14.1.9.2 Product offered 263
14.1.10 DYNAREX CORPORATION 265
14.1.10.1 Business overview 265
14.1.10.2 Product offered 265
14.2 OTHER PLAYERS 266
14.2.1 OWENS & MINOR 266
14.2.2 ADVACARE PHARMA 267
14.2.3 FIRST AID BANDAGE COMPANY 268
14.2.4 MÖLNLYCKE HEALTH CARE AB 269
14.2.5 ALLCARE 270
14.2.6 NARANG MEDICAL LIMITED 271
14.2.7 AEGIS LIFESCIENCES 272
14.2.8 SUNDARAM SURGICAL 273
14.2.9 ASPEN SURGICAL PRODUCTS 274
14.2.10 OMNI INTERNATIONAL CORP 274
15 APPENDIX 275
15.1 DISCUSSION GUIDE 275
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 280
15.3 CUSTOMIZATION OPTIONS 282
15.4 RELATED REPORTS 282
15.5 AUTHOR DETAILS 283